Compound information
- Natural Products
- ZC1770410
- Molecular Formula
- C17H16ClNO4
- Molecular Weight
- 333.076785672 g/mol
- Structure
-
- IUPAC Name
- (2R)-2-(benzyloxycarbonylamino)-3-(4-chlorophenyl)propanoic acid
- InChI
- InChI=1S/C17H16ClNO4/c18-14-8-6-12(7-9-14)10-15(16(20)21)19-17(22)23-11-13-4-2-1-3-5-13/h1-9,15H,10-11H2,(H,19,22)(H,20,21)/t15-/m1/s1
- InChI Key
- LEWUPPXPENCAKM-OAHLLOKOSA-N
- SMILES
- O=C(N[C@H](Cc1ccc(Cl)cc1)C(=O)O)OCc1ccccc1
- Source
- ZINC000002002736
Warheads
- Carbamate
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 23 | Ring Count | 2 |
Heteroatom Count | 6 | Rotatable Bond Count | 6 |
Hydrogen Bond Acceptor Count | 3 | Hydrogen Bond Donor Count | 2 |
Topological Polar Surface Area | 75.63 Å2 | LogP | 3.451 |
LogS | -3.693 | LogD | 2.834 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.01 | Pgp substrate | 0.009 |
HIA | 0.963 | F20 % | 0.994 |
F30 % | 0.931 | Caco-2 | -5.468 |
MDCK | -4.852 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.486 | PPB | 93.099 |
VD | 0.39 | Fu | 1.486 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.036 | CYP1A2 substrate | 0.711 |
CYP2A6 substrate | 0.263 | CYP2B6 substrate | 0.45 |
CYP2C19 inhibitor | 0.178 | CYP2C19 substrate | 0.394 |
CYP2C8 substrate | 0.806 | CYP2C9 inhibitor | 0.167 |
CYP2C9 substrate | 1.0 | CYP2D6 inhibitor | 0.317 |
CYP2D6 substrate | 0.411 | CYP2E1 substrate | 0.385 |
CYP3A4 inhibitor | 0.16 | CYP3A4 substrate | 0.723 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.765 | CL | 0.502 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.015 | Hepatotoxicity | 0.861 |
Mutagenicity | 0.044 | Rat Oral Acute Toxicity | 0.117 |
FDAMDD | 0.129 | Skin Sensitization | 0.0 |
Carcinogenicity | 0.008 | Eye Corrosion | 0.004 |
Eye Irritation | 0.005 | Respiratory Toxicity | 0.006 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | -0.26 | IGC50 | 3.001 |
LC50FM | 3.792 | LC50DM | 5.169 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.388 | NR-AR-LBD | 0.312 |
NR-AhR | 0.009 | NR-Aromatase | 0.027 |
NR-ER | 0.356 | NR-ER-LBD | 0.334 |
NR-PPAR-gamma | 0.615 | SR-ARE | 0.059 |
SR-ATAD5 | 0.248 | SR-HSE | 0.086 |
SR-MMP | 0.012 | SR-p53 | 0.031 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.